We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
+1.31%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$132M
AUM Growth
–
Cap. Flow
+$135M
Cap. Flow
% of AUM
102%
Top 10 Holdings %
Top 10 Hldgs %
75.66%
Holding
59
New
59
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.9M |
| 2 |
Idexx Laboratories
IDXX
|
+$8.4M |
| 3 |
Adobe
ADBE
|
+$8.29M |
| 4 |
Microsoft
MSFT
|
+$5.83M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.71M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.7% |
| 2 | Technology | 24.86% |
| 3 | Communication Services | 5.77% |
| 4 | Financials | 3.6% |
| 5 | Industrials | 2.71% |
Similar funds
SC
SC
AGP
SFPG
TP
S
SS
LAM
Bourne Lent Asset Management's Q1 2015 Portfolio in Review
Q1 2015 is the first quarter with a 13F filing on record for Bourne Lent Asset Management, which disclosed 59 positions worth $132M. Its ten largest holdings account for 76% of the portfolio.
Its largest position is Celgene Corp: 467,549 shares worth $53.9M.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, followed by Technology and Communication Services.
- Bourne Lent Asset Management's largest Q1 2015 buy was Celgene Corp: 467,549 shares worth $53.9M.
- Bourne Lent Asset Management's ten largest holdings make up 76% of its $132M portfolio in Q1 2015.
- Bourne Lent Asset Management disclosed 59 positions in Q1 2015, its first 13F filing on record.
Based on Bourne Lent Asset Management's 13F filing for Q1 2015, filed 14 May 2015.